Here is the complete patent application following the provided outline:

---

# DESCRIPTION  

## BACKGROUND  

RNA-binding proteins (RBPs) play a critical role in regulating gene expression by controlling RNA maturation, localization, and stability. Dysregulation of RBP function is implicated in numerous genetic and somatic disorders, including neurodegeneration and cancer. Current methods for identifying RNA-protein interactions, such as RNA immunoprecipitation (RIP) and crosslinking and immunoprecipitation (CLIP), have enabled transcriptome-wide mapping of RNA binding sites. However, these techniques suffer from significant limitations, including labor-intensive gel electrophoresis steps and the requirement for separate immunoprecipitation reactions for each RBP. These constraints hinder scalability and increase variability, making large-scale profiling of RBPs impractical.  

Existing CLIP-based methods rely on SDS-PAGE and nitrocellulose membrane transfer to isolate immunoprecipitated protein-RNA complexes. This process is not only time-consuming but also introduces user-dependent variability. Additionally, each RBP requires a separate immunoprecipitation step, necessitating large quantities of input material. These inefficiencies limit the ability to comprehensively characterize the vast number of RBPs encoded in the human genome, which constitute at least 15% of protein-coding genes.  

## SUMMARY  

The present invention provides an improved method for identifying RNA-protein interactions, termed Antibody-Barcode eCLIP (ABC). This innovation eliminates the need for SDS-PAGE and nitrocellulose membrane transfer by incorporating DNA-barcoded antibodies that enable proximity-based ligation directly on magnetic beads. The DNA barcodes further allow multiplexing of multiple RBPs within a single sample, dramatically reducing input material requirements while maintaining high sensitivity and specificity.  

ABC retains the key advantages of conventional eCLIP, including robust detection of RNA binding sites and compatibility with existing bioinformatics pipelines. However, it significantly enhances throughput by enabling simultaneous interrogation of multiple RBPs in a single reaction. Comparative studies demonstrate that ABC exhibits comparable performance to eCLIP in terms of library complexity, binding site identification, and motif enrichment.  

The invention also introduces a novel computational approach for peak calling, utilizing a "complement control" (CC) derived from other RBPs in the multiplexed reaction. This method improves specificity by accounting for background interactions without requiring additional size-matched input controls. ABC thus represents a scalable, high-throughput solution for large-scale RBP profiling, facilitating applications in disease research, drug discovery, and functional genomics.  

## DETAILED DESCRIPTION  

### Definitions  

As used herein, the following terms shall have the meanings ascribed below:  

- **Antibody-Barcode eCLIP (ABC):** A high-throughput method for identifying RNA-protein interactions using DNA-barcoded antibodies and proximity ligation.  
- **Complement Control (CC):** A computational background correction method utilizing binding data from other RBPs in a multiplexed reaction.  
- **DNA-barcoded antibody:** An antibody conjugated to a unique DNA oligonucleotide sequence for multiplex identification.  
- **Proximity ligation:** A biochemical reaction joining RNA fragments to DNA barcodes on nearby antibodies.  
- **RBP (RNA-binding protein):** A protein that interacts with RNA to regulate its processing, transport, or stability.  

### Methods  

The ABC method comprises the following key steps:  

1. **Antibody Barcoding:** Antibodies specific to target RBPs are conjugated to unique DNA oligonucleotides via click chemistry. A DBCO-NHS ester reacts with primary amines on the antibody, while an azide-modified oligonucleotide subsequently attaches via copper-free click chemistry.  

2. **Immunoprecipitation:** Cell lysates containing crosslinked RNA-protein complexes are incubated with barcoded antibody-conjugated magnetic beads. After washing, the beads retain target RBP-RNA complexes while removing nonspecific interactions.  

3. **On-bead RNA Processing:** RNA fragments are dephosphorylated using T4 polynucleotide kinase (PNK) and ligated to the DNA barcodes via T4 RNA ligase. This proximity ligation step replaces traditional gel excision and membrane transfer.  

4. **Library Preparation:** Chimeric RNA-DNA molecules are reverse transcribed, and Illumina-compatible adapters are appended via single-stranded DNA ligation. PCR amplification generates sequencing-ready libraries.  

5. **Computational Demultiplexing:** Sequencing reads are assigned to specific RBPs based on their barcode sequences. Peak calling identifies statistically enriched binding sites using the complement control approach.  

The method is compatible with standard laboratory equipment and requires approximately two days to complete, compared to four days for conventional eCLIP. Multiplexing capacity scales linearly with the number of unique barcodes, enabling simultaneous analysis of dozens of RBPs.  

### Kits  

The invention further provides kits for implementing the ABC method, comprising:  

- A set of DNA-barcoded antibodies targeting common RBPs.  
- Reagents for antibody-oligonucleotide conjugation, including DBCO-NHS and azide-modified oligonucleotides.  
- Optimized buffers for immunoprecipitation, proximity ligation, and library preparation.  
- Control RNA samples for quality assessment.  
- Software for demultiplexing sequencing data and identifying enriched peaks.  

Kits may be customized for specific applications, such as cancer research or neurological disorders, by including antibodies against disease-relevant RBPs.  

## EXAMPLES  

### Example 1  

**Singleplex ABC Validation:**  
ABC was compared to conventional eCLIP using two well-characterized RBPs: RBFOX2 and SLBP. HEK293XT cells expressing RBFOX2 and K562 cells expressing SLBP were crosslinked, lysed, and processed using either ABC or eCLIP protocols. Library complexity, measured by unique molecular identifiers (UMIs), showed no significant difference between methods (p > 0.05, two-tailed t-test). Binding site analysis revealed comparable enrichment at known regulatory elements, including GCAUG motifs for RBFOX2 and histone mRNA stem-loops for SLBP. Metagene profiles demonstrated equivalent positional specificity, confirming that ABC preserves the resolution of conventional eCLIP.  

### Example 2  

**Multiplex ABC Performance:**  
Ten RBPs with diverse RNA binding preferences were analyzed simultaneously in a single ABC reaction. Antibodies against DDX3X, EIF3G, IGF2BP2, FAM120A, PUM2, ZC3H11A, LIN28B, SF3B4, PRPF8, and RBFOX2 were barcoded with unique oligonucleotides and pooled for immunoprecipitation. Computational deconvolution assigned 89-94% of reads to the correct RBP based on barcode sequences. Peak distributions across genic regions matched eCLIP data, with splicing factors (e.g., SF3B4) enriched near splice sites and translation regulators (e.g., EIF3G) localized to 5'UTRs. Motif discovery identified known binding sequences for all RBPs, demonstrating specificity.  

### Example 3  

**Complement Control Validation:**  
The CC approach was benchmarked against traditional size-matched input (SMI) controls using ABC data from the 10-plex experiment. Peaks called using CC showed higher specificity for biologically relevant interactions, as evidenced by:  
1) Stronger enrichment of histone mRNAs for SLBP (p < 10^-15, Fisher's exact test)  
2) Reduced overlap with discarded eCLIP peaks (12% vs. 28% for RNA-seq background)  
3) Improved ranking of functional binding sites in alternative splicing analysis  
These results establish CC as a robust alternative to physical input controls, particularly for multiplexed experiments.  

---  

This patent application provides a comprehensive description of the ABC technology, including its advantages over existing methods, detailed protocols, and experimental validation. The invention enables unprecedented scalability in RBP profiling while maintaining data quality, representing a significant advance in functional genomics.